Research output per year
Research output per year
Personal profile
Research interests
Drug Utilisation Research and Pharmacoepidemiology, diabetes & cardiovascular treatment. Prescribing quality and indicators. Medication adherence. Shared decision making and decision support tools.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study
Abou, J., Crutzen, S., Tromp, V., Heringa, M., Van Marum, R., Elders, P., Taxis, K., Denig, P. & Hugtenburg, J., Mar-2022, In: Drugs & Aging. 39, 3, p. 209-221 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure) -
Differences in Older Patients' Attitudes Toward Deprescribing at Contextual and Individual Level
Oktora, M. P., Edwina, A. E. & Denig, P., 11-Feb-2022, In: Frontiers in public health. 10, 7 p., 795043.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Erratum to: Precision medicine approaches for diabetic kidney disease: opportunities and challenges
Tye, S. C., Denig, P. & Heerspink, H. J. L., 8-Feb-2022, (E-pub ahead of print) In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1 p., gfab296.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile -
Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach
de Vries, E., Bakker, E., Francisca, R. D. C., Croonen, S., Denig, P. & Mol, P. G. M., 29-Mar-2022, (E-pub ahead of print) In: Drug Safety. 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Downloads (Pure) -
Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
Tye, S. C., de Vries, S. T., Wanner, C., Denig, P. & Heerspink, H., 25-Jan-2022, In: Frontiers in Pharmacology. 12, 10 p., 786706.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure)
-
Deprescribing in de praktijk: belemmerende en bevorderende factoren bij artsen en patiënten.
Petra Denig (Invited speaker)
28-Sep-2022Activity: Talk and presentation › Professional or public presentation › Professional
-
Deprescribing in de praktijk: belemmerende en bevorderende factoren bij artsen en patiënten.
Petra Denig (Invited speaker)
6-Apr-2022Activity: Talk and presentation › Professional or public presentation › Professional
-
Verbeteren van geneesmiddelgebruik: hoe maken we het meetbaar?
Petra Denig (Keynote speaker)
19-May-2022Activity: Talk and presentation › Professional or public presentation › Professional
-
38th ICPE International Conference on Pharmacoepidemiology
Petra Denig (Contributor)
2022Activity: Organising and attending an event › Organising and contributing to an event › Academic
-
Getting deprescribing into clinical practice: Deprescribing guidelines
Petra Denig (Invited speaker)
6-Sep-2022 → 7-Sep-2022Activity: Talk and presentation › Academic presentation › Academic
Datasets
-
GIANTT Groningen Initiative to ANalyse Type 2 diabetes Treatment
Denig, P. (Creator), Universitair Medisch Centrum Groningen / Rijksuniversiteit Groningen, 1-Jan-2007
http://www.giantt.nl and one more link, http://www.giantt.nl/enoutline.htm (show fewer)
Dataset
-
Gender differences in adverse drug reactions: knowledge synthesis and exploration
de Vries, S. (Contributor), Denig, P. (Contributor), Burgers, J. S. (Contributor), Kleefstra, N. (Contributor), Mol, P. G. (Contributor) & van Puijenbroek, E. (Contributor), University of Groningen, 2-Aug-2019
DOI: 10.34894/q0xnjs, https://doi.org/10.34894%2Fq0xnjs
Dataset
-
Quality assessment of pharmacotherapy in patients with chronic kidney disease: development of indicators
Denig, P. (Contributor), University of Groningen, 1-Jan-2019
Dataset
Press / Media
-
Minderen en stoppen van medicatie
19/07/2021
1 Media contribution
Press/Media: Public Engagement Activities › Popular
-
Interview Farma Magazine
Martina Ambroz, Sieta de Vries, Klaas Hoogenberg & Petra Denig
18/02/2021
1 item of Media coverage
Press/Media: Public Engagement Activities › Professional
-
Waarom pillen steeds beter werken [Dagblad van het Noorden]
Job Boven, van, Jos Kosterink & Petra Denig
07/03/2020
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Deprescribing: hoe minder, hoe beter
01/11/2019
1 Media contribution
Press/Media: Public Engagement Activities › Professional
-
Verschillen in bijwerkingen bij man en vrouw onder de loep
14/04/2017
1 item of Media coverage
Press/Media: Research › Popular
Prizes
-
Among the most popular scientific papers in Drug Safety 2018
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2018
Prize: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2019
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2019
Prize: Other distinction › Academic
-
-
Nomination of Top downloaded paper 2018-2019 in BJCP
de Vries, Sieta (Recipient), Denig, Petra (Recipient), Mol, Peter (Recipient) & van Puijenbroek, Eugène (Recipient), 30-Apr-2019
Prize: Other distinction › Academic
-
Top 10% most cited in 2021 PlosOne papers published in 2019
Denig, Petra (Recipient), 2021
Prize › Academic